A Penny for Your Clots? Examining Tax Incentives for Whole Blood Donation under FDA Guidelines
Food and Drug Law Journal | Volume 75 | Number 1
Formal Dispute Resolution and the Food and Drug Administration
Food and Drug Law Journal | Volume 75 | Number 1
Does Attorney Advertising Stimulate Adverse Event Reporting? (Open Access)
Does Attorney Advertising Stimulate Adverse Event Reporting? Elizabeth C. Tippett & Brian K. Chen* ABSTRACT Law firms and legal referral companies spend about $114 million per year[1] on television advertisements soliciting patients for mass tort lawsuits against drug companies and medical device makers (“drug injury advertising”).[2] These advertisements warn viewers about a particular adverse [...]
What Is “Appropriate for the Protection of the Public Health” Under the U.S. Tobacco Control Act? (Open Access)
What Is “Appropriate for the Protection of the Public Health” Under the U.S. Tobacco Control Act? Eric N. Lindblom* Abstract In 2009, the U.S. Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) gave the U.S. Food and Drug Administration (FDA) extensive new powers to issue rules and take other regulatory actions to [...]
Blockchainizing Food Law: Promises and Perils of Incorporating Distributed Ledger Technologies to Food Safety, Traceability, and Sustainability Governance
Food and Drug Law Journal | Volume 74 | Number 4
Comparing Dietary Supplement Regulations in the U.S. and Abroad
Food and Drug Law Journal | Volume 74 | Number 4
Remarks by the Acting Commissioner of Food and Drugs (Open Access)
Food and Drug Law Journal | Volume 74 | Number 3
Open the Floodgates: The Potential Impact on Litigation Against FDA if the Supreme Court Reverses or Curtails Chevron Deference (Open Access)
Food and Drug Law Journal | Volume 74 | Number 3
Ruling by Repute: Agency Reputation on Judicial Affirmance of Agency Action
Food and Drug Law Journal | Volume 74 | Number 3
The 505(b)(2) Drug Approval Pathway (Open Access)
Food and Drug Law Journal | Volume 74 | Number 3
